Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 28, 2025
Transforming Wellness: Abundant Health Introduces RENEW Protocols for Lasting Relief
GlobeNewswire
·
March 28, 2025
Davenport, Iowa, March 28, 2025 (GLOBE NEWSWIRE) -- Abundant Health Physical Medicine, a leading integrative wellness clinic in the Midwest, is transforming the treatment of neuropathy, chronic joint pain, autoimmune conditions, and spinal health through …
Norton Orthopedic Institute surgeon performs new robotic-assisted shoulder replacement
GlobeNewswire
·
March 28, 2025
LOUISVILLE, Ky., March 28, 2025 (GLOBE NEWSWIRE) -- New robotic technology has arrived at Norton Brownsboro Hospital. Justin M. Givens, M.D., orthopedic surgeon with Norton Orthopedic Institute, is among the first five surgeons in the country — and the …
Ethos Cannabis Expands Pennsylvania Presence with Aurora Launch and Title Sponsorship at the Pennsylvania Cannabis Convention
GlobeNewswire
·
March 28, 2025
PHILADELPHIA, March 28, 2025 (GLOBE NEWSWIRE) -- Ethos Cannabis (or “The Company”), a leading multistate operator with a strong presence in Pennsylvania, Massachusetts, and Ohio, announces the launch of Aurora, a new innovative line of infused live resin …
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
GlobeNewswire
·
March 28, 2025
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable …
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
GlobeNewswire
·
March 28, 2025
LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
GlobeNewswire
·
March 28, 2025
BETHESDA, Md., March 28, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
GlobeNewswire
·
March 28, 2025
PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative treatments for cancer, infectious diseases, and fibrosis, today announced that the China National …
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
GlobeNewswire
·
March 28, 2025
CB1 inverse agonism is a clinically validated mechanism to induce weight loss CRB-913 is markedly more peripherally restricted compared to monlunabant and rimonabant SAD/MAD Phase 1 trial scheduled for completion Q3 2025 and Phase 1b dose-range finding …
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
GlobeNewswire
·
March 28, 2025
Marlton, NJ, March 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it received European CE Mark approval for an expanded …
Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results
GlobeNewswire
·
March 28, 2025
FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the …
Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
GlobeNewswire
·
March 28, 2025
Regional Medical Leaders Embrace Daxor’s ezBVA Lab Service Oak Ridge, TN, March 28, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), Daxor, the global leader in blood volume measurement technology, today announces a significant expansion into …
Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
GlobeNewswire
·
March 28, 2025
THE WOODLANDS, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin development …
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
GlobeNewswire
·
March 28, 2025
- Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor patient population - - Solnerstotug continues to demonstrate a well-tolerated safety and tolerability profile - - …
Bio-Path Holdings Reports Full Year 2024 Financial Results
GlobeNewswire
·
March 28, 2025
HOUSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs …
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
GlobeNewswire
·
March 28, 2025
- Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) - - Initiated CORE-008 Clinical Trial of Cretostimogene Monotherapy in High- …
60 Degrees Pharmaceuticals Announces 2024 Annual Results
GlobeNewswire
·
March 28, 2025
FY 2024 net product revenues increased 140% to $607.6 thousand. FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 thousand. WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ( …
Winstrol Steroid: Benefits, Side Effects, Results & Buy Winstrol Pills Alternatives From CrazyBulk
GlobeNewswire
·
March 28, 2025
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- There exist numerous approaches to enhance muscle growth, a tantalizing prospect for many. However, achieving substantial muscle gains is far from instantaneous. Merely engaging in physical activities won't …
Ligandrol (LGD-4033) SARMs: Benefits, Results & Buy Ligandrol Pills Alternatives From CrazyBulk
GlobeNewswire
·
March 28, 2025
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- A significant portion of the populace leads lifestyles that compromise both cognitive and physical functionality. Prioritizing a healthy lifestyle is paramount for optimal brain and body performance, fostering a …
ProvaDent Reviews (Is It Safe And Legit?) Investigative Report On Ingredients, Side Effects, And Benefits!
GlobeNewswire
·
March 28, 2025
TALLMADGE, Ohio, March 28, 2025 (GLOBE NEWSWIRE) -- ProvaDent is precisely fabricated to support oral health by promoting a balanced oral microbiome. It works to encourage the growth of beneficial bacteria while reducing harmful ones. Maintaining this …
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GlobeNewswire
·
March 28, 2025
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for COPD in more than a decade in Japan and the sixth approved …